Bildkälla: Stockfoto

Xbrane Biopharma: Follow-up Note on Submission Withdrawal - Redeye

Redeye leaves a more elaborate comment on yesterday morning's news that Xbrane has withdrawn its Xlucane submission to the FDA.

Redeye leaves a more elaborate comment on yesterday morning's news that Xbrane has withdrawn its Xlucane submission to the FDA.
Börsvärldens nyhetsbrev
ANNONSER